Zanamivir is an antiviral drug used to treat infections caused by influenza A and B viruses. It is a neuraminidase inhibitor, meaning it works by blocking the activity of the influenza virus enzyme neuraminidase, which is essential for the virus to spread within the body. Zanamivir is administered through inhalation and is available in both capsule and powder form. It is typically used to treat acute uncomplicated influenza in adults and children over the age of five. Zanamivir is one of several drugs used to treat infectious diseases, and is often used in combination with other drugs to increase its effectiveness. It is generally well-tolerated, with few side effects. However, it is not effective against all strains of influenza, and resistance to the drug has been reported in some cases. The zanamivir market is highly competitive, with several major pharmaceutical companies producing and marketing the drug. These include GlaxoSmithKline, Novartis, Sanofi, and Daiichi Sankyo. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
